Surveillance of megakaryocytic function by measurement of CD61-exposing microparticles in allogeneic hematopoietic stem cell recipients

Clinical Transplantation

Volumn 25, Issue 3, 2011, Pages

  Rank, Andreas ^a   Nieuwland, Rienk ^b   Delker, Ruth ^a   Pihusch, Verena ^a   Wilkowski, Ralf ^a   Toth, Bettina ^c   Kolb, Hans Jochem ^a,d   Pihusch, Rudolf ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^d INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

Graft versus host disease; Hematopoietic stem cell transplantation; Hepatopathy; Megakaryocyte; Microparticles

Indexed keywords

AMSACRINE; CD61 ANTIGEN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTARABINE; FLUDARABINE; LIPOCORTIN 5; METHOTREXATE; MYCOPHENOLIC ACID; PREDNISOLONE; THYMOCYTE ANTIBODY;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CELL COUNT; CELL DAMAGE; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; HUMAN; HYPERBILIRUBINEMIA; IMMUNOSUPPRESSIVE TREATMENT; MALE; MEGAKARYOCYTE; MICROANGIOPATHY; POSTOPERATIVE INFECTION; POSTOPERATIVE MICROANGIOPATHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; STAINING; THROMBOCYTE; THROMBOTIC THROMBOCYTOPENIC PURPURA; WHOLE BODY RADIATION;

EID: 79958761981     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2011.01406.x     Document Type: Article

References (46)

1. VanWijk MJ, VanBavel E, Sturk A et al. Microparticles in cardiovascular diseases. Cardiovasc Res 2003: 59: 277.
2. Van Wijk JM, Nieuwland R, Boer K et al. Microparticle subpopulations are increased in pre-eclampsia: possible involvement in vascular dysfunction? Am J Obstet Gynecol 2002: 187: 450.
3. Myers DD, Hawley AE, Farris DM et al. P-selectin and leukocyte microparticles are associated with venous thrombogenesis. J Vasc Surg 2003: 38: 1075.
4. Sellam J, Proulle V, Jüngel A et al. Increased levels of circulating microparticles in primary Sjögren's syndrome, systemic lupus erythematosus and rheumatoid arthritis and relation with disease activity. Arthritis Res Ther 2009: 11: R156.
5. Tamagawa-Mineoka R, Katoh N, Kishimoto SJ. Platelet activation in patients with psoriasis: increased plasma levels of platelet-derived microparticles and soluble P-selectin. J Am Acad Dermatol 2009: 3: 1.
6. Erdbruegger U, Grossheim M, Hertel B et al. Diagnostic role of endothelial microparticles in vasculitis. Rheumatology (Oxford) 2008: 47: 1820.
7. Feng B, Chen Y, Luo Y et al. Circulating level of microparticles and their correlation with arterial elasticity and endothelium-dependent dilation in patients with type 2 diabetes mellitus. Atherosclerosis 2010: 208: 264.
8. Kuriyama N, Nagakane Y, Hosomi A et al. Evaluation of factors associated with elevated levels of platelet-derived microparticles in the acute phase of cerebral infarction. Clin Appl Thromb Hemost 2010: 16: 26.
9. Li X, Cong H. Platelet-derived microparticles and the potential of glycoprotein IIb/IIIa antagonists in treating acute coronary syndrome. Tex Heart Inst J 2009: 36: 134.
10. Toth B, Nieuwland R, Kern M et al. Systemic changes in haemostatic balance are not associated with increased levels of circulating microparticles in women with recurrent spontaneous abortion. Am J Reprod Immunol 2008: 59: 159.
11. Lok CA, Böing AN, Sargent IL et al. Circulating platelet-derived and placenta-derived microparticles expose Flt-1 in preeclampsia. Reprod Sci 2008: 15: 1002.
12. Toth B, Liebhardt S, Steinig K et al. Platelet-derived microparticles and coagulation activation in breast cancer patients. Thromb Haemost 2008: 100: 663.
13. Kelton JG. Heparin-induced thrombocytopenia: an overview. Blood Rev 2002: 16: 77.
14. Nieuwland R, Berckmans RJ, Rotteveel-Eijkman RC et al. Cell-derived microparticles generated in patients during cardiopulmonary bypass are highly procoagulant. Circulation 1997: 96: 3534.
15. Thiagarajan P, Tait JF. Collagen-induced exposure of anionic phospholipid in platelets and platelet-derived microparticles. J Biol Chem 1991: 266: 24302.
16. Chang CP, Zhao J, Wiedmer T et al. Contribution of platelet microparticle formation and granule secretion to the transmembrane migration of phosphatidylserine. J Biol Chem 1993: 268: 7171.
17. Sims PJ, Faioni EM, Wiedmer T et al. Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity. J Biol Chem 1988: 263: 18205.
18. Gilbert GE, Sims PJ, Wiedmer T et al. Platelet-derived microparticles express high affinity receptors for factor VIII. J Biol Chem 1991: 266: 17261.
19. Hoffman M, Monroe DM, Roberts HR. Coagulation factor IXa binding to activated platelets and platelet-derived microparticles: a flow cytometric study. Thromb Haemost 1992: 68: 74.
20. Barry OP, Kazanietz MG, Pratico D et al. Arachidonic acid in platelet microparticles up-regulates cyclooxygenase-2-dependent prostaglandin formation via a protein kinase C/mitogen-activated protein kinase-dependent pathway. J Biol Chem 1999: 274: 7545.
21. Barry OP, Pratico D, Lawson JA et al. Transcellular activation of platelets and endothelial cells by bioactive lipids in platelet microparticles. J Clin Invest 1997: 99: 2118.
22. Barry OP, Pratico D, Savani RC et al. Modulation of monocyte-endothelial cell interactions by platelet microparticles. J Clin Invest 1998: 102: 136.
23. Nomura S, Tandon NN, Nakamura T et al. High-shear-stress-induced activation of platelets and microparticles enhances expression of cell adhesion molecules in THP-1 and endothelial cells. Atherosclerosis 2001: 158: 277.
24. Flaumenhaft R, Dilks JR, Richardson J et al. Megakaryocyte-derived microparticles: direct visualization and distinction from platelet-derived microparticles. Blood 2009: 113: 1112.
25. Rank A, Nieuwland R, Delker R et al. Cellular origin of platelet-derived microparticles in vivo. Thromb Res 2010: 126: 255.
26. Holler E, Kolb HJ, Hiller E et al. Microangiopathy in patients on cyclosporine prophylaxis who developed acute graft-versus-host disease after HLA-identical bone marrow transplantation. Blood 1989: 73: 2018.
27. Rio B, Andreu G, Nicod A et al. Thrombocytopenia in venoocclusive disease after bone marrow transplantation or chemotherapy. Blood 1986: 67: 1773.
28. Glucksberg H, Storb R, Fefer A et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation 1974: 18: 295.
29. Berckmans RJ, Nieuwland R, Böing A et al. Cell-derived microparticles circulate in healthy humans and support low grade thrombin generation. Thromb Haemost 2001: 83: 639.
30. Cramer EM, Norol F, Guichard J et al. Ultrastructure of platelet formation by human megakaryocytes cultured with the Mpl ligand. Blood 1997: 89: 2336.
31. Van Doormaal FF, Kleinjan A, Di Nisio M et al. Cell-derived microvesicles and cancer. Neth J Med 2009: 67: 266.
32. Tesselaar ME, Romijn FP, Van Der Linden IK et al. Microparticle-associated tissue factor activity: a link between cancer and thrombosis? J Thromb Haemost 2007: 5: 520.
33. Falati S, Liu Q, Gross P et al. Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin. J Exp Med 2003: 197: 1585.
34. Janowska-Wieczorek A, Majka M, Kijowski J et al. Platelet-derived microparticles bind to hematopoietic stem/progenitor cells and enhance their engraftment. Blood 2001: 98: 3143.
35. Baj-Krzyworzeka M, Majka M, Pratico D et al. Platelet-derived microparticles stimulate proliferation, survival, adhesion, and chemotaxis of hematopoietic cells. Exp Hematol 2002: 30: 450.
36. Bekkum van DW. Radiation sensitivity of the hemopoietic stem cell. Rad Res 1991: 128: S4.
37. Odell TT, Jackson CW, Friday TJ. Effects of radiation in the thrombocytopoietic system of mice. Rad Res 1971: 48: 107.
38. Rank A, Nieuwland R, Liebhardt S et al. Apheresis platelet concentrates contain platelet derived and endothelial cell derived microparticles. Vox Sang 2010: Jul 30 (epub ahead of print).
39. Gawaz M, Fateh-Moghadam S, Pilz G et al. Severity of multiple organ failure (MOF) but not of sepsis correlates with irreversible platelet degranulation. Infection 1995: 23: 16.
40. Pihusch R, Holler E, Mühlbayer D et al. The impact of antithymocyte globulin on short term toxicity after allogeneic stem cell transplantation. Bone Marrow Transplant 2002: 30: 347.
41. Anasetti C, Rybka W, Sullivan KM et al. Graft-v-host disease is associated with autoimmune-like thrombocytopenia. Blood 1989: 73: 1054.
42. Carlo-Stella C, Tabilio A, Regazzi E et al. Effect of chemotherapy for acute myelogenous leukemia on hematopoietic and fibroblast marrow progenitors. Bone Marrow Transplant 1997: 20: 465.
43. Marsh JC, Harhalakis N, Dowding C et al. Recurrent graft failure following syngeneic bone marrow transplantation for aplastic anaemia. Bone Marrow Transplant 1989: 4: 581.
44. Pihusch R, Wegner H, Salat C et al. Flow cytometric findings in platelets of patients following allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2002: 30: 381.
45. Pihusch R, Salat C, Schmidt E et al. Hemostatic complications in bone marrow transplantation: a retrospective analysis of 447 patients. Transplantation 2002: 74: 1303.
46. Van Der Pol E, Hoekstra AG, Sturk AO, Van Leeuwen TG, Nieuwland R. Optical and non-optical methods for detection and characterisation of microparticles and exosomes. J Thromb Haemost 2010: 8: 2596.